Market Research Future adds new report of “Global Liquid biopsy market by type from 2013 to 2022” it contains Company information, geographical data.
Global Liquid biopsy Market by application is projected to grow at a CAGR of 28.0% and is expected to reach US$ 17,372.28 million by 2022. Globally, the North America accounted for the largest market share in 2016.
Global Liquid biopsy is one of the fastest market. The liquid biopsy technique provides a ... Read more
OG Analysis, a global market research firm, has announced the release of their Global Liquid Biopsy Market size, Outlook and Opportunities 2019- 2025: By Circulating Biomarker (Extracellular Vesicles (Evs), Circulating Tumor Cells, Circulating Tumor DNA (CTDNA), Cell-Free DNA and Other Circulating Biomarkers), By Product and Service (Instruments, Assay Kits and Services), By Application (Non-Cancer ... Read more
Liquid Biopsy Market is estimated to value over USD 8.4 billion by 2027 end and register a CAGR of over 20% during the forecast period 2020 to 2027.
The report initiates from the outline of business surroundings and explains the commercial summary of chain structure. Moreover, it analyses forecasts By Biomarker Type, By End-user , By Region and Liquid Biopsy Market Trends.
The Liquid Biopsy Market is estimated to be valued at Us$ 13,220 Mn in 2022 and is expected to exhibit a CAGR Of 4.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Liquid biopsy is a non-invasive blood test for detecting various types of cancer in the body. It allows doctors to obtain sample of tumor DNA circulating in the ... Read more
Liquid biopsy tests involve the sampling and analysis of blood or other body fluids for detecting and monitoring cancer. They offer minimally invasive alternatives to tissue biopsies for detecting various cancers. Advancements in liquid biopsy technologies have enabled the detection of minimal residual disease and monitoring of treatment responses. Next generation sequencing and digital PCR techniques are being applied to analyze cell-free DNA or circulating tumor cells in blood samples. ... Read more
